NIH-funded research NIH-funded research

Nicotinamide riboside and aging muscle function in older veterans

Official title: Impacts of nicotinamide riboside on functional capacity and muscle physiology in older Veterans

Funded at Kansas City VA Medical Center · NIH-11216514 · Data updated 2026-11-12

A study tests whether nicotinamide riboside can improve physical function and muscle health in healthy adults aged 65–85 who are veterans.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKansas City VA Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJuly 1, 2021
Project endJune 30, 2026
Funding year2027
NIH project number5I01RX003396-06
Project IDNIH-11216514 on NIH RePORTER

Who could benefit from this research

Could help

Healthy adults aged 65–85 who are veterans and willing to participate in a 3‑month NR or placebo trial.

Less likely to help

Older adults outside the 65–85 range or those with significant mobility limitations or comorbidities may not benefit.

What this research studies

This project will test if a supplement called nicotinamide riboside (NR) can improve how well older adults move, their muscle function, and related cellular signals. It uses a double‑blind, randomized design to compare NR versus placebo over 3 months in healthy veterans aged 65–85. The goal is to see if NR helps maintain or enhance daily activity, strength, and muscle biology as people age. Results could inform whether NR is a safe way to support aging muscles in humans.

Why it matters

Potential benefit: If successful, NR could become a simple strategy to help older adults maintain independence and mobility.

How similar studies have gone: Prior animal studies showed improved activity and mitochondrial health with NR; human data are limited, making this study exploratory in humans.

Where this research is happening

  • Kansas City VA Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Seldeen, Kenneth Ladd — Kansas City VA Medical Center
  • Study coordinator: Seldeen, Kenneth Ladd

Related research

Other NIH-funded projects on the same topics.

  • Home-based high-intensity interval training to reduce frailty in older veterans

    This program tests whether a short, home-based high-intensity interval training (HIIT) routine can help older U.S. veterans become stronger, more resilient, and less likely to become frail.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-11360817

  • Islet transplant with a protective scaffold for diabetes in Veterans

    A VA research team is testing a new way to transplant insulin-producing cells inside a protective scaffold to help veterans with diabetes achieve stable blood sugar.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-11190408

  • Ovarian hormones and liver mitochondrial health in fatty liver

    This project looks at how the loss of ovarian hormones affects liver energy function in fatty liver and whether exercise or estrogen can help women, including postmenopausal female Veterans.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-11123339

  • Investigating the causes and treatments of inflammatory bowel diseases in veterans

    This study is looking into how inflammatory bowel diseases (IBD) affect veterans more than others, and it aims to find new ways to treat these conditions by exploring certain proteins and gut bacteria, which could lead to better treatments and fewer complications like colon cancer.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-11063227

  • Targeting cancer growth in pancreatic cancer using a new drug delivery system

    This study is testing a new way to deliver a cancer-fighting drug specifically for people with pancreatic cancer, aiming to make the treatment more effective and less harmful by using a special carrier that releases the medicine right where it's needed in the tumor.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-11003658

  • Investigating new treatments for triple-negative breast cancer

    This study is looking at ways to slow down the growth of triple-negative breast cancer by focusing on a protein called CCN5/WISP-2, with the hope of finding new treatment options that could help patients like you have better outcomes.

    NIH research Kansas City VA Medical Center · Kansas City, United States · NIH-10948930

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.